BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34217492)

  • 21. The American Society for Radiation Oncology's 2015 Core Physics Curriculum for Radiation Oncology Residents.
    Burmeister J; Chen Z; Chetty IJ; Dieterich S; Doemer A; Dominello MM; Howell RM; McDermott P; Nalichowski A; Prisciandaro J; Ritter T; Smith C; Schreiber E; Shafman T; Sutlief S; Xiao Y
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1298-303. PubMed ID: 27354135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hope: oncology's missing breakthrough.
    Corn BW
    Ann Oncol; 2012 Nov; 23(11):2775. PubMed ID: 23002279
    [No Abstract]   [Full Text] [Related]  

  • 23. US Government Payer-Funded Trials to Address Oncology's Drug-Dosing Conundrum: A Congressional Call to Action?
    Strohbehn GW; Lichter AS; Ratain MJ
    J Clin Oncol; 2023 May; 41(14):2488-2492. PubMed ID: 36780590
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of Whether the American Society of Clinical Oncology's Value Framework and the European Society for Medical Oncology's Magnitude of Clinical Benefit Scale Measure Absolute or Relative Clinical Survival Benefit: An Analysis of Randomized Clinical Trials.
    Saluja R; Everest L; Cheng S; Cheung M; Chan KKW
    JAMA Oncol; 2019 Aug; 5(8):1188-1194. PubMed ID: 31095255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The elderly with cancer: oncology's excluded patients].
    Feliu J; Rodríguez Aizcorbe JR; Ordóñez A
    Med Clin (Barc); 1992 Apr; 98(13):505-9. PubMed ID: 1369816
    [No Abstract]   [Full Text] [Related]  

  • 26. Choosing wisely: the American Society for Radiation Oncology's top 5 list.
    Hahn C; Kavanagh B; Bhatnagar A; Jacobson G; Lutz S; Patton C; Potters L; Steinberg M
    Pract Radiat Oncol; 2014; 4(6):349-55. PubMed ID: 25407853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stocking oncology's medicine cabinet.
    Kiberstis PA; Travis J
    Science; 2017 Mar; 355(6330):1142-1143. PubMed ID: 28302820
    [No Abstract]   [Full Text] [Related]  

  • 28. Oncology's perfect storm: the next decade.
    Newcomer LN
    Am J Manag Care; 2005 Dec; 11(17 Suppl):S507-8. PubMed ID: 16336065
    [No Abstract]   [Full Text] [Related]  

  • 29. American Psychosocial Oncology Society (APOS) celebrates Psycho-Oncology's 30 years of success.
    Archer-Nanda E; Greer JA
    Psychooncology; 2022 Apr; 31(4):557. PubMed ID: 35396893
    [No Abstract]   [Full Text] [Related]  

  • 30. Musings on Patient Care and Polarization After JAMA Oncology's Erroneous Report That Complementary Medicine Kills.
    Weeks J
    Explore (NY); 2019; 15(2):82-87. PubMed ID: 30709782
    [No Abstract]   [Full Text] [Related]  

  • 31. The Oncology Care Model: Oncology's First Foray Away From Volume and Toward Value-Based Care.
    Song A; Csik VP; Leader A; Maio V
    Am J Med Qual; 2019; 34(4):321-323. PubMed ID: 30650993
    [No Abstract]   [Full Text] [Related]  

  • 32. Oncology's energetic pipeline.
    Garber K
    Nat Biotechnol; 2010 Sep; 28(9):888-91. PubMed ID: 20829819
    [No Abstract]   [Full Text] [Related]  

  • 33. Charting a strategic direction for the American Society of Preventive Oncology's Survivorship Interest Group.
    Trentham-Dietz A; Buist DS; Kelly KM; Jacobson JS; Paskett E;
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1912-3. PubMed ID: 17855715
    [No Abstract]   [Full Text] [Related]  

  • 34. The 340b drug discount program: oncology's optical illusion.
    Eagle D; Buell RL; Vacirca J
    Oncology (Williston Park); 2013 Nov; 27(11):1068, 1070, 1072. PubMed ID: 24575533
    [No Abstract]   [Full Text] [Related]  

  • 35. American Society of Clinical Oncology's 2008 Gastrointestinal Cancers Symposium (ASCO GI), January 25-27, 2008, Orlando, Florida.
    Fricker J
    Mol Oncol; 2008 Jun; 2(1):5-7. PubMed ID: 19383321
    [No Abstract]   [Full Text] [Related]  

  • 36. Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment.
    Weber JS; Levit LA; Adamson PC; Bruinooge SS; Burris HA; Carducci MA; Dicker AP; Gönen M; Keefe SM; Postow MA; Thompson MA; Waterhouse DM; Weiner SL; Schuchter LM
    J Clin Oncol; 2017 Jan; 35(2):139-140. PubMed ID: 27893329
    [No Abstract]   [Full Text] [Related]  

  • 37. Mary Gospodarowicz: focused on oncology's unfinished agenda.
    Lane R
    Lancet; 2021 Jun; 397(10290):2140. PubMed ID: 34090597
    [No Abstract]   [Full Text] [Related]  

  • 38.
    Cannistra SA
    J Clin Oncol; 2019 Dec; 37(35):3333-3334. PubMed ID: 31805249
    [No Abstract]   [Full Text] [Related]  

  • 39. The American Society of Clinical Oncology's Blueprint for Transforming Clinical and Translational Cancer Research.
    Meropol NJ; Kris MG; Winer EP
    J Clin Oncol; 2012 Mar; 30(7):690-1. PubMed ID: 22215747
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of the American Society of Clinical Oncology's Conflict of Interest Policy on Information Overload.
    Boothby A; Wang R; Cetnar J; Prasad V
    JAMA Oncol; 2016 Dec; 2(12):1653-1654. PubMed ID: 27560393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.